High-Content Screening of Eukaryotic Kinase Inhibitors Identify CHK2 Inhibitor Activity Against .
Frontiers in microbiology • Vol. 11 • 2020
The IUPHAR Guide to Immunopharmacology: connecting immunology and pharmacology.
Immunology • Vol. 160, Issue 1 • 2020
Development of a novel azaspirane that targets the Janus kinase-signal transducer and activator of transcription (STAT) pathway in hepatocellular carcinoma in vitro and in vivo.
The Journal of biological chemistry • Vol. 289, Issue 49 • 2014
Drug repurposing screen identifies lestaurtinib amplifies the ability of the poly (ADP-ribose) polymerase 1 inhibitor AG14361 to kill breast cancer associated gene-1 mutant and wild type breast cancer cells.
Breast cancer research : BCR • Vol. 16, Issue 3 • 2014
